secwatch.observer — SEC 8-K summary
======================================

Issuer:     ORTHOPEDIATRICS CORP (KIDS)
CIK:        0001425450
Form:       8-K
Filed at:   2023-01-09T23:59:59+00:00
Accession:  0001425450-23-000004
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

OrthoPediatrics Q4 preliminary revenue $31M (+25% YoY); FY22 $122.3M (+25%); guides FY23 $146-149M
--------------------------------------------------------------------------------

- Preliminary Q4 2022 net revenue $31.0M, up 25% vs $24.8M in Q4 2021.
- Full year 2022 preliminary net revenue $122.3M, up 25% from $98.0M in 2021.
- Domestic Q4 revenue +15% YoY; international Q4 revenue +67% YoY.
- FY 2023 guidance: net revenue $146M-$149M, implying 20-22% growth.
- CEO cites viral respiratory infection disruptions at children's hospitals as a headwind.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1425450/000142545023000004/0001425450-23-000004-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1425450/000142545023000004/kids-20230109.htm
  HTML page:      https://secwatch.observer/filing/0001425450-23-000004

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer